Clinical Trials Browser

OTHER × Prostatic Neoplasms × Temozolomide × Clear all

NCT04019327 2025-12-15

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms